Loading…
Medpace Holdings, Inc. is projected to rise to $800.79 by 2027, a +49% move from its current price of $538.23. MEDP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $528.06 | $538.36 | $548.86 | +0.02% |
| Jul 15 | $523.97 | $538.48 | $553.39 | +0.05% |
| Jul 16 | $520.89 | $538.61 | $556.93 | +0.07% |
| Jul 17 | $518.32 | $538.74 | $559.95 | +0.09% |
| Jul 18 | $516.09 | $538.86 | $562.64 | +0.12% |
| Jul 19 | $514.08 | $538.99 | $565.10 | +0.14% |
| Jul 20 | $512.26 | $539.12 | $567.38 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $512.26 | $539.12 | $567.38 | +0.16% |
| Week 2 | $502.36 | $540.00 | $580.47 | +0.33% |
| Week 3 | $495.08 | $540.89 | $590.95 | +0.49% |
| Week 4 | $489.15 | $541.78 | $600.08 | +0.66% |
| Week 5 | $484.08 | $542.68 | $608.36 | +0.83% |
| Week 6 | $479.62 | $543.57 | $616.05 | +0.99% |
| Week 7 | $475.61 | $544.46 | $623.28 | +1.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Medpace Holdings, Inc. operates in Healthcare, providing clinical research-based drug and medical device development services across North America, Europe, Asia, South America, Africa, and Australia.
The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas, and provides development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. It also offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials.
Medpace was founded in 1992 and is based in Cincinnati, Ohio.
Medpace Holdings, Inc. (MEDP) operates in the Healthcare sector. The current price is $557.60 and the market cap is $15.92B, with a rank of 663.
The near-term price outlook is informed by a 30-day technical picture, which currently shows bullish sentiment and a price action framed by key levels.
The 30-day range spans $488.30 to $636.74, with the current price near resistance at $557.60 and a defined support at $421.87. This combination supports a cautiously constructive view in the near term.
A major floor 26.9% below — a decisive break under it would weaken the trend.
The nearest floor, 17.2% below — buyers have tended to step in here.
The nearest ceiling, 5.0% above — a clean break opens room to run.
A major ceiling 18.1% above — clearing it would confirm fresh momentum.
Key MEDP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MEDP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $543.42 | Sell | $539.19 | Sell |
| MA 10 | $540.96 | Sell | $532.98 | Buy |
| MA 20 | $508.02 | Buy | $514.16 | Buy |
| MA 50 | $463.22 | Buy | $486.97 | Buy |
| MA 100 | $465.96 | Buy | $483.60 | Buy |
| MA 200 | $514.94 | Buy | $478.94 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.58 | Neutral |
| Stoch RSI (14) | 43.14 | Neutral |
| CCI (20) | 58.18 | Neutral |
| Williams %R (14) | -24.55 | Info |
| MACD (12,26,9) | 1.07 | Buy |
| ROC (12) | 13.68 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 75.45 | Neutral |
| TRIX (15) | 0.72 | Buy |
| Awesome (5,34) | 60.28 | Buy |
| Ultimate (7,14,28) | 62.87 | Neutral |
| Momentum (10) | 18.27 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 535.61 | Buy |
| ADX (14) | 32.89 | Buy |
| ATR (14) | 9.05 | Info |
The 30-day technical picture is bullish, with RSI14 at 80. The stock’s moving averages show a potential growth path: SMA50 is $451.75 and SMA200 is $513.79.
Key price levels are reflected in support at $421.87 and resistance at $557.60, while the 30-day price range runs from $488.30 to $636.74. Annualized volatility is 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $393.42 | $538.23 | $717.73 | 0% | Neutral | |
| $654.88 | $800.79 | $1,024.46 | +49% | Bullish | |
| $720.50 | $898.05 | $1,180.70 | +67% | Bullish | |
| $802.47 | $1,016.08 | $1,364.98 | +89% | Bullish | |
| $941.40 | $1,208.55 | $1,653.43 | +125% | Bullish | |
| $988.59 | $1,285.07 | $1,786.50 | +139% | Bullish | |
| $1,146.37 | $1,507.49 | $2,126.17 | +180% | Bullish | |
| $1,414.99 | $1,880.91 | $2,687.89 | +249% | Bullish | |
| $1,579.34 | $2,120.86 | $3,067.75 | +294% | Bullish | |
| $1,764.99 | $2,393.26 | $3,501.10 | +345% | Bullish | |
| $2,777.48 | $3,933.10 | $6,035.14 | +631% | Bullish | |
| $4,904.78 | $7,465.70 | $12,295.36 | +12.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $393.42 | $538.23 | $632.25 | +0.00% |
| August 2026 | $454.56 | $532.20 | $636.68 | -1.12% |
| September 2026 | $467.34 | $549.89 | $663.16 | +3.32% |
| October 2026 | $479.18 | $566.21 | $687.49 | +2.97% |
| November 2026 | $479.54 | $568.67 | $694.41 | +0.43% |
| December 2026 | $491.44 | $584.71 | $717.73 | +2.82% |
Click any year to see its month-by-month MEDP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MEDP to range from $393.42 to $717.73 through 2026. The $538.23 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MEDP price prediction for 2027 points to an average of $800.79 (low $654.88, high $1,024.46) — a potential gain of +49% on today's $538.23. Momentum favours further upside here.
In 2028, MEDP is projected to trade between $720.50 and $1,180.70, averaging $898.05 — a potential gain of +67% from today's $538.23. That is up +12% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Medpace Holdings, Inc.'s 2029 outlook centres on $1,016.08, within a $802.47 to $1,364.98 range. That is up +13% on the projected 2028 average. That marks a +89% change versus current levels. Momentum favours further upside here.
By 2030, MEDP could reach as high as $1,653.43, with a base case around $1,208.55 and support toward $941.40 — roughly +125% from $538.23. Buyers look set to stay in control over this stretch.
Expect MEDP to range from $988.59 to $1,786.50 through 2031. The $1,285.07 average target implies a +139% move from current prices. That is up +6% on the projected 2030 average. Momentum favours further upside here.
The MEDP price prediction for 2032 points to an average of $1,507.49 (low $1,146.37, high $2,126.17) — a potential gain of +180% on today's $538.23. Buyers look set to stay in control over this stretch.
In 2033, MEDP is projected to trade between $1,414.99 and $2,687.89, averaging $1,880.91 — a potential gain of +249% from today's $538.23. That is up +25% on the projected 2032 average. Momentum favours further upside here.
Medpace Holdings, Inc.'s 2034 outlook centres on $2,120.86, within a $1,579.34 to $3,067.75 range. That is up +13% on the projected 2033 average. That marks a +294% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MEDP could reach as high as $3,501.10, with a base case around $2,393.26 and support toward $1,764.99 — roughly +345% from $538.23. Momentum favours further upside here.
Expect MEDP to range from $2,777.48 to $6,035.14 through 2040. The $3,933.10 average target implies a +631% move from current prices. That is up +64% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MEDP price prediction for 2050 points to an average of $7,465.70 (low $4,904.78, high $12,295.36) — a potential gain of +12.9x on today's $538.23. Momentum favours further upside here.
Investing $1,000 in MEDP today (≈ 1.857942 MEDP) could be worth
$13,870.83
+$12,870.83 (+1287%) by 2050 · US Dollar
Based on the average projected MEDP price of $7,465.7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MEDPwould be worth at today's price.
$1,000 invested in MEDP on Jul 10, 2025 (≈ 3.046551 MEDP) would be worth
$1,639.75
+$639.75 (+64.0%) today · 1.64× · US Dollar
Based on a MEDP entry price of $328.24 vs. today's $538.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $557.6 | $965.26 | -3.5% |
| 1 month ago | $465.73 | $1,155.67 | +15.6% |
| 3 months ago | $493.53 | $1,090.57 | +9.1% |
| 6 months ago | $599.21 | $898.23 | -10.2% |
| 1 year ago | $328.24 | $1,639.75 | +64.0% |
| All time (5.0y) ago | $182.9 | $2,942.76 | +194.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MEDP forecast.
Our base-case forecast reaches $1,100.00 around 2030.
Implied market cap at $1,100.00: $31.42B
The multi-year forecast begins in 2026 with a min of $393.42, an avg of $557.60, and a max of $765.97, ROI 0%, and sentiment NEUTRAL.
From 2027 to 2030 the outlook remains bullish, with 2027 avg $849.87 (ROI 52.4%), 2028 avg $958.72 (71.9%), 2029 avg $1,111.12 (99.3%), and 2030 avg $1,329.16 (138.4%).
Further years build on that path: 2031 avg $1,416.67 (ROI 154.1%), 2032 avg $1,705.48 (205.9%), 2033 avg $2,140.49 (283.9%), 2034 avg $2,402.96 (330.9%), and 2035 avg $2,748.78 (393%). 2040 shows a strong step with avg $4,583.23 (ROI 722%), and 2050 projects avg $9,030.49 (ROI 1519.5%).
Tap a question to reveal the answer.
2030 min $1,029.83; avg $1,329.16; max $1,831.06; ROI 138.4%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages: 2027 avg $849.87 (ROI 52.4%), 2028 avg $958.72 (71.9%), 2029 avg $1,111.12 (99.3%), 2030 avg $1,329.16 (138.4%). The 2026 value is $557.60 with neutral sentiment.
Yes. The forecast includes 2040 max $7,107.25 and 2050 max $15,061.62, indicating extensive upside and the potential to exceed $5,000.
Current price is $557.60 and market cap is $15.92B.
RSI14 is 80, sentiment is BULLISH. SMA50 is $451.75, SMA200 is $513.79; support is $421.87 and resistance is $557.60. The 30-day range runs from $488.30 to $636.74 and annualized volatility is 40%.
Medpace Holdings, Inc. Community Discussion
0Share your Medpace Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.